Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Jun 2022
Nat Commun

Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa

Autoren
Silva JC et al.
Jun 2022
Blood Cancer J

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review

Autoren
Piechotta V et al.
Jun 2022
NPJ Vaccines

Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens

Autoren
Ibanez J et al.
Namibian mother and daughter, dressed in T-shirts and skirts, the woman additionally wearing a green-brownish-coloured headscarf, squatting in front of a light blue-coloured wall.Eine afrikanische Mutter mit Tocher, beide tragen T-Shirts und Röcke, die Mutter zudem ein grün-schwarz gemustertes gebundenes Kopftuch. Beide hocken vor einer hellblau gesprichenen Wand.

© Christoph Lange

© Christoph Lange
Aug 14 2022

BCG tuberculosis vaccine only effective in early childhood

In the early 20th century, French scientists Albert Calmette and Camille Guérin developed a vaccine from the bovine tuberculosis bacterium Mycobacterium bovis, which was named BCG (Bacillus Calmette

Electron microscopic image of green-coloured MERS-coronavirus particles. Clearly visible are the spike-proteins on the surface of the virus particles that resemble a crown and give the coronavirus its name.

© NIAID

© NIAID
Aug 1 2022

Booster vaccination with newly developed vaccine against MERS-CoV leads to robust long-lasting immunity

Besides SARS-CoV and SARS-CoV-2, the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is among the highly pathogenic coronaviruses that can lead to severe respiratory disease and death. It is

Jul 2022
Cell Rep Med

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Autoren
Weskamm L
Fathi A
Raadsen M
Apr 2022
Vaccines (Basel)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response

Autoren
Patyna S et al.
Apr 2022
BMJ Open

Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study

Autoren
Faye SLB et al.
Apr 2022
Int J Mol Sci

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus

Autoren
Kim YC et al.
Apr 2022
Eur J Immunol

Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients

Autoren
Hagemann K et al.

Pagination

Previous page ‹‹
Seite 15 Seite 16 Seite 17 Seite 18 Current page 19 Seite 20 Seite 21 Seite 22 Seite 23
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states